Dr. Mark Litzow

MD – Oncologist & Hermatologist

Profile

Dr. Mark Litzow

MD, University of Minnesota Medical School
Residency in Internal Medicine, Hennepin County Medical Center
Fellowship in Hematology & Oncology, University of Minnesota

Current Role At Neovita

Dr. Litzow serves as a senior Hematology and Oncology specialist at NeoVita Oncology, focusing on blood disorders, leukemia, and stem cell transplantation. He leads multidisciplinary teams in both patient care and clinical research initiatives.

Expertise & Specialization

• Hematologic malignancies, including leukemia and lymphoma
• Stem cell transplantation and cellular therapies
• Clinical trials and translational research
• Patient-centered oncology care

Memberships & Affiliation

• American Society of Hematology (ASH)
• American Society of Clinical Oncology (ASCO)
•International Bone Marrow Transplant Society (IBMT)

Biography

Dr. Mark Litzow earned his MD from the University of Minnesota Medical School, completed his residency in Internal Medicine at the University of Minnesota, and pursued a fellowship in Hematology/Oncology at the same institution. He has conducted extensive research in leukemia, lymphoma, and stem cell transplantation, publishing numerous high-impact studies in peer-reviewed journals. Currently at NeoVita Oncology, he combines his clinical expertise with research to advance the treatment of blood cancers and improve patient outcomes worldwide.

Career highlights & Achievements

Dr. Litzow is internationally recognized for his expertise in hematologic malignancies and stem cell transplantation. He has made significant contributions to research on leukemia, lymphoma, and innovative transplant approaches. Dr. Litzow has authored numerous peer-reviewed publications, participated in landmark clinical trials, and received awards for excellence in patient care and research. His work has helped shape modern approaches to cellular therapies and transplantation for blood cancers.